Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AltaRex offers further analysis of OvaRex results

Feb. 5, 2002

Preclinical milestone reached for Crucell human anti-CD46 antibody

Feb. 4, 2002

AHP describes preparation of novel soluble pegylated rapamycin derivatives

Feb. 4, 2002

Board recommends continuation of Biomira's phase IIb trial of BLP25 in NSCLC

Jan. 31, 2002

Rituximab + CHOP as a new drug combination for aggressive NHL

Jan. 29, 2002

Phase IIb results reported for OvaRex in metastatic ovarian cancer

Jan. 29, 2002

Patient enrollment completed in trial of G17DT in gastric cancer

Jan. 25, 2002

Progen enrolls first patient in phase II trial of PI-88 in multiple myeloma

Jan. 24, 2002

Survival data announced from phase II trial of GD-0039 in metastatic renal cancer

Jan. 23, 2002

Arius postpones murine ARH460-23 antibody development

Jan. 22, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...